Progyny (PGNY) Receivables (2018 - 2026)

Progyny (PGNY) has 9 years of Receivables data on file, last reported at $299.0 million in Q1 2026.

• Receivables for Q1 2026 came in at $299.0 million, down 16.51% year-over-year; the trailing twelve-month figure through Mar 2026 was $299.0 million (down 16.51% YoY), and the FY2025 annual result was $254.2 million, down 9.97% from the prior year.
• Receivables climbed to $299.0 million in Q1 2026 per PGNY's latest filing, from $254.2 million in the prior quarter.
• Over five years, Receivables peaked at $370.3 million in Q2 2024 and troughed at $229.4 million in Q1 2022.
• A 5-year average of $309.7 million and a median of $310.5 million in 2023 frame the typical range for Receivables.
• The sharpest annual moves came in 2022 and 2026: Receivables jumped 102.36% in 2022, then slipped 16.51% in 2026.
• A 5-year view of Receivables shows it stood at $283.0 million in 2022, then gained by 1.41% to $287.0 million in 2023, then declined by 1.62% to $282.3 million in 2024, then dropped by 9.97% to $254.2 million in 2025, then grew by 17.64% to $299.0 million in 2026.
• Business Quant data shows PGNY's Receivables at $299.0 million in Q1 2026, $254.2 million in Q4 2025, and $296.8 million in Q3 2025.